Ujjivan Financial services reported best quarterly results with strong revenue growth and improving asset quality. The NII for the quarter rose by 76 per cent yoy and 24.3 per cent qoq to Rs. 269 crore in Q4FY18 vs Rs.152 crore in Q4FY17 and Rs.216 crore in Q3FY18.

The most sought-after IPO of recent times, Indostar Capital Finance IPO, was subscribed – per cent till 4 pm on its last day of subscription, on Friday.

Investors should use capture ratio intelligently to zero in on funds that suit their risk-return profile. 

Diversification is the key to reduce risk. To manage large investments efficiently, proper diversification among the various asset classes is very important. 

The share price of Max Ventures and Industries surged by over 3 per cent on the bourses in Friday’s trade as the company subsidiary Max Speciality Films Limited inaugurated its new BOpp1 manufacturing line on Thursday.

During Q4FY18, company’s domestic ad revenue jumped by 24.9 per cent yoy whereas subscription revenue grew by 18.1 per cent yoy.

The USFDA has granted final approval to Glenmark Pharmaceuticals Inc, US for Clobetasol Propionate Cream USP, 0.05 per cent, which is the generic version of Temovate Cream, 0.05 per cent, of Fougera Pharmaceuticals, Inc.

Following stocks are close to their 52-week low as at 12.21 p.m. on May 11, 2018.

The markets on May 11, 2018 opened up. BSE Sensex is trading at 35,344.36, up by 98.09 points and the Nifty is trading at 10,752.10, up by 35.55 points.

Union Bank of India dropped about 5 per cent intraday on Friday to Rs. 83.25 per share, their lowest since July 26, 2006 on the back of net loss of Q4FY18.